Bioreference Laboratories an Opko Health Company
Clinical Laboratory
Based in NJ
AI Overview
With $1.0M in lobbying spend across 26 quarterly filings, Bioreference Laboratories an Opko Health Company is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2019 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $175K |
| 2020 | $210K |
| 2021 | $200K |
| 2022 | $250K |
| 2023 | $100K |
| 2024 | $92K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Bioreference Laboratories an Opko Health Company disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Laboratory Payment
Laboratory Regulation
Medicare/Medicaid
Health Information Technology
HR 3107-Prior authorization for payment for genetic testing
Regulation of clinical laboratory testing
Payment for clinical lab testing/PAMA
Regulation of clinical laboratory testing
Payment for laboratory testing
Prior authorization for genetic testing
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.